Cart
sales@molnova.com
Allisartan Isoproxil
CAS No. 947331-05-7
Allisartan Isoproxil( —— )
Catalog No. M27845 CAS No. 947331-05-7
Allisartan Isoproxil, an angiotensin II receptor antagonist, is used to treat mild to moderate essential hypertension.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 264 | Get Quote |
|
| 5MG | 403 | Get Quote |
|
| 10MG | 592 | Get Quote |
|
| 25MG | 888 | Get Quote |
|
| 50MG | 1242 | Get Quote |
|
| 100MG | 1701 | Get Quote |
|
| 500MG | 3402 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameAllisartan Isoproxil
-
NoteResearch use only, not for human use.
-
Brief DescriptionAllisartan Isoproxil, an angiotensin II receptor antagonist, is used to treat mild to moderate essential hypertension.
-
DescriptionAllisartan Isoproxil, an angiotensin II receptor antagonist, is used to treat mild to moderate essential hypertension.
-
In Vitro——
-
In VivoAnimal Model:Femal and male Sprague-Dawley ratsDosage:20, 80 and 320 mg/kg Administration:Result:Decreased body-weight gain at 320 mg/kg/day in both sexes as well as at the 80-mg/kg/day dose in females. Decreased erythrocyte parameters in males, and decreased heart weight and exacerbation of chronic progressive nephropathy (CPN) severity in males at 80 and 320 mg/kg/day.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorFurin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number947331-05-7
-
Formula Weight553.02
-
Molecular FormulaC27H29ClN6O5
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (180.83 mM)
-
SMILESCCCCc1nc(Cl)c(C(=O)OCOC(=O)OC(C)C)n1Cc1ccc(cc1)-c1ccccc1-c1nnn[nH]1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
2',5'-Dideoxyadenosi...
2',5'-Dideoxyadenosine is a potent and non-competitive adenylyl cyclase inhibitor via binding the P-site (IC50: 3 μM).2',5'-Dideoxyadenosine (20-150 mM), like adenosine, dependently and reversibly inhibits the positive inotropic and chronotropic effect of beta-adrenergic stimulation with isoproterenol (8-54 pmol) up to 70% and 50%, respectively.
-
Lobaplatin (D-19466)
Lobaplatin (D-19466) is a diastereometric mixture of platinum(II) complexes. Lobaplatin (D-19466) shows activity for a variety of tumour types and is a promising antitumour chemotherapeutic agent.
-
PF-00835231
PF-00835231 is a CoV-2 cysteine 3C-like protease (3CLpro) inhibitor, with IC50s of 0.27 nM and 4 nM for SARS CoV-2 and SARS CoV-1 3CLpro, respectively.PF-00835231 is the active compound of the first anti-3CLpro regimen in clinical trials.
